| Literature DB >> 29053969 |
Sally E Wenzel1, Yulia Y Tyurina2, Jinming Zhao3, Claudette M St Croix4, Haider H Dar2, Gaowei Mao5, Vladimir A Tyurin2, Tamil S Anthonymuthu5, Alexandr A Kapralov2, Andrew A Amoscato2, Karolina Mikulska-Ruminska6, Indira H Shrivastava7, Elizabeth M Kenny5, Qin Yang5, Joel C Rosenbaum8, Louis J Sparvero2, David R Emlet5, Xiaoyan Wen5, Yoshinori Minami3, Feng Qu2, Simon C Watkins4, Theodore R Holman9, Andrew P VanDemark8, John A Kellum5, Ivet Bahar10, Hülya Bayır11, Valerian E Kagan12.
Abstract
Ferroptosis is a form of programmed cell death that is pathogenic to several acute and chronic diseases and executed via oxygenation of polyunsaturated phosphatidylethanolamines (PE) by 15-lipoxygenases (15-LO) that normally use free polyunsaturated fatty acids as substrates. Mechanisms of the altered 15-LO substrate specificity are enigmatic. We sought a common ferroptosis regulator for 15LO. We discovered that PEBP1, a scaffold protein inhibitor of protein kinase cascades, complexes with two 15LO isoforms, 15LO1 and 15LO2, and changes their substrate competence to generate hydroperoxy-PE. Inadequate reduction of hydroperoxy-PE due to insufficiency or dysfunction of a selenoperoxidase, GPX4, leads to ferroptosis. We demonstrated the importance of PEBP1-dependent regulatory mechanisms of ferroptotic death in airway epithelial cells in asthma, kidney epithelial cells in renal failure, and cortical and hippocampal neurons in brain trauma. As master regulators of ferroptotic cell death with profound implications for human disease, PEBP1/15LO complexes represent a new target for drug discovery.Entities:
Keywords: GPX4; PEBP1/15LO complex; acute kidney injury; asthma; brain trauma; cell death; ferroptosis; ferrostatin-1; phosphatidylethanolamine oxidation; redox phospholipidomics
Mesh:
Substances:
Year: 2017 PMID: 29053969 PMCID: PMC5683852 DOI: 10.1016/j.cell.2017.09.044
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582